Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T14:57:28.728Z.
Calculation as of: 2026-10-06T14:57:28.728Z.
Quote observation: 2026-10-06T14:55:31.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9f9faf5d94760910c623181769e7db2d3dbfaf2deb8efb054b569f6f0254c4bb
PEG RATIO
N/A
Jaguar Health, Inc.
Market Cap
$2.67M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Jaguar Health, Inc. (JAGX) | $2.67M | N/A |
| Nuwellis, Inc. (NUWE)vs › | $2.64M | N/A |
| iSpecimen Inc. (ISPC)vs › | $2.63M | N/A |
| bioAffinity Technologies, Inc. (BIAF)vs › | $2.56M | N/A |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.54M | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $2.92M | N/A |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.40M | N/A |
| GeoVax Labs, Inc. (GOVX)vs › | $2.36M | N/A |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.32M | N/A |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.04M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
